CAS 16004-15-2|4-Iodobenzyl bromide
Introduction：Basic information about CAS 16004-15-2|4-Iodobenzyl bromide, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 4-Iodobenzyl bromide | ||
|---|---|---|---|
| CAS Number | 16004-15-2 | Molecular Weight | 296.931 |
| Density | 2.1±0.1 g/cm3 | Boiling Point | 260.1±15.0 °C at 760 mmHg |
| Molecular Formula | C7H6BrI | Melting Point | 78-82 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 111.1±20.4 °C |
| Symbol | GHS05 | Signal Word | Danger |
Names
| Name | 4-Iodobenzyl Bromide |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 2.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 260.1±15.0 °C at 760 mmHg |
| Melting Point | 78-82 °C(lit.) |
| Molecular Formula | C7H6BrI |
| Molecular Weight | 296.931 |
| Flash Point | 111.1±20.4 °C |
| Exact Mass | 295.869751 |
| LogP | 3.95 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.656 |
| InChIKey | BQTRMYJYYNQQGK-UHFFFAOYSA-N |
| SMILES | BrCc1ccc(I)cc1 |
| Storage condition | 2-8°C |
Safety Information
| Symbol | GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C:Corrosive; |
| Risk Phrases | R34 |
| Safety Phrases | S26-S36/37/39-S45 |
| RIDADR | UN 3261 8/PG 2 |
| WGK Germany | 3 |
| Hazard Class | 8.0 |
| HS Code | 2903999090 |
Customs
| HS Code | 2903999090 |
|---|---|
| Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Articles7
More Articles| Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound. J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... | |
| Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction. J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... | |
| Synthesis of new 1,2,3-triazole derivatives of uracil and thymine with potential inhibitory activity against acidic corrosion of steels. Molecules 18(4) , 4613-27, (2013) Ten 1,4-disubstituted 1,2,3-triazoles were synthesized from one of 1-(azido-methyl)benzene, 1-(azidomethyl)-4-fluorobenzene, 1-(azidomethyl)-4-chlorobenzene, 1-(azidomethyl)-4-bromobenzene or 1-(azido... |
Synonyms
| 4-(Bromomethyl)iodobenzene |
| α-Bromo-p-iodotoluene |
| 1-(Bromomethyl)-4-iodobenzene |
| MFCD00209656 |
| IR D1E |
| Benzene, 1-(bromomethyl)-4-iodo- |
| 4-Iodobenzyl bromide |
| α-Bromo-4-iodotoluene |
